Related Experiment Video

Updated: Jun 17, 2025

Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
07:20

Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity

Published on: December 21, 2012

15.9K

Study on the Mechanisms of Glrα3 in Pain Sensitization of Endometriosis

Peiya Fan1,2, Rong Liu1,2, Yan Li1,2

  • 1Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.

International Journal of Molecular Sciences
|August 10, 2024
PubMed

Insights

Glycine receptor alpha 3 (Glrα3) is crucial in endometriosis pain. Inhibiting Glrα3 alleviates pain and anxiety by reducing central sensitization and glial activation, offering new therapeutic targets.

Area of Science:

  • Neuroscience
  • Pain research
  • Gynecology

Background:

  • Endometriosis frequently causes chronic pelvic pain, anxiety, and depression.
  • Central sensitization plays a key role in endometriosis-associated pain.
  • Glycine receptor alpha 3 (Glrα3) involvement in pain pathways is under investigation.

Purpose of the Study:

  • To investigate the role and mechanism of Glrα3 in central pain sensitization in endometriosis.
  • To explore Glrα3 as a potential therapeutic target for endometriosis-related pain.

Main Methods:

  • Utilized a Glrα3 knockout mouse model of endometriosis.
  • Employed behavioral tests, qPCR, immunofluorescence, Nissl staining, MRI, and Western blot.
  • Assessed pain, anxiety-like behaviors, neuronal changes, and glial activation.

Main Results:

  • Endometriosis induced hyperalgesia and anxiety-depressive behaviors correlated with increased Glrα3 expression.
  • Chronic pain led to gray matter changes in sensory and insular cortices, with Glrα3 involvement.
  • Glrα3 inhibition alleviated pain, reduced neuronal abnormalities, and decreased glial activation.

Conclusions:

  • Glrα3 is a significant mediator of central pain sensitization in endometriosis.
  • Targeting Glrα3 offers a promising therapeutic strategy for endometriosis-related pain and associated psychological symptoms.
  • Glrα3 absence regulates pain by inhibiting glial activation and maintaining neuronal stability.
Keywords:
Glrα3central sensitizationendometriosispain

More Related Videos

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

1.5K
Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies08:16

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

6.1K

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
555
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.4K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
639
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.8K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
323